Table 1. Allele and overall genotype association of rs71305152 with glioma.

Cohort	Subject	Allele					Genotype
	n (M/F Ratio b )	I % (n)	D % (n)	OR c	95% CI d	P e	II % (n)	ID % (n)	DD % (n)	P f
Glioma	350 (1.54)	33.57 (235)	66.43 (465)				15.14 (53)	36.86 (129)	48.00 (168)
Non-glioma a	354 (1.51)	35.45 (251)	64.55 (457)	0.920	0.739–1.146	0.458	12.71 (45)	45.48 (161)	41.81 (148)	0.066
Control	463(1.02)	34.77 (322)	65.23 (604)	0.948	0.770–1.166	0.613	11.45 (53)	46.65 (216)	41.90 (194)	0.016

^a Non-glioma cohort includes lung cancer, leukemia and lymphoma cohorts;

^b M/F Ratio is the ratio of successfully genotyped male to female;

^c OR is the odds ratio;

^d 95% CI is 95% confidence interval;

^e P values pertain to allele frequency difference between glioma cohort and either non-glioma cancer cohort or control cohort;

^f P values pertain to overall genotype frequency difference between glioma cohort and either non-glioma cancer cohort or control cohort;

P value of less than 0.05 is highlighted.